SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 133 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $562,581 | -28.4% | 145,370 | +10.3% | 0.00% | -100.0% |
Q2 2023 | $785,254 | -29.1% | 131,754 | -61.1% | 0.00% | 0.0% |
Q1 2023 | $1,107,778 | +17.1% | 338,770 | +41.4% | 0.00% | 0.0% |
Q4 2022 | $946,100 | -61.0% | 239,519 | -40.8% | 0.00% | -50.0% |
Q3 2022 | $2,429,000 | -4.2% | 404,790 | +2.7% | 0.00% | 0.0% |
Q2 2022 | $2,535,000 | +220.5% | 394,250 | +311.8% | 0.00% | – |
Q1 2022 | $791,000 | -73.3% | 95,742 | -49.9% | 0.00% | -100.0% |
Q4 2021 | $2,961,000 | +140.9% | 191,263 | +250.5% | 0.00% | +100.0% |
Q3 2021 | $1,229,000 | -58.4% | 54,576 | -63.7% | 0.00% | -50.0% |
Q2 2021 | $2,953,000 | +3638.0% | 150,206 | +6235.1% | 0.00% | – |
Q1 2021 | $79,000 | – | 2,371 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |